Investigating Participation Patterns Among Stage IV Melanoma Patients
Part of paid clinical trials in San Francisco, California.
- Sponsor
- Power Life Sciences Inc.
- Study ID
- NCT06093594
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Stage IV Melanoma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
Clinical trials, specifically focused on stage IV melanoma, are crucial in assessing the safety and efficacy of new treatments for this disease. These trials serve as fundamental instruments in determining whether emerging medications outperform standard therapies, providing compelling evidence to support wider implementation. The main goal is to thoroughly scrutinize trial completion rates and voluntary withdrawals among this particular group of patients.
Key Dates
- Start date
- Nov 30, 2024
- Status verified
- Oct 2023
- Primary completion
- Nov 30, 2025
- Completion
- Nov 30, 2026
Study Design
- Enrollment
- 500 participants (estimated)
Primary Outcome Measure
Number of stage IV melanoma patients who decide to enroll in a clinical research [ Time Frame: 3 months ]
Central Contacts
- Michael B Gill415-900-4227
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Power Life Sciences | San Francisco | California | 94107 |